<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Jiapaer Z</submitter><funding>Tianshan Youth Foundation of Xinjiang</funding><funding>National Natural Science Foundation of China</funding><funding>Massachusetts General Hospital Institutional fund</funding><pagination>155</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9865796</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>15(1)</volume><pubmed_abstract>Cardiovascular diseases (CVDs) remain the world's leading cause of death despite the best available healthcare and therapy. Emerging as a key mediator of intercellular and inter-organ communication in CVD pathogenesis, extracellular vesicles (EVs) are a heterogeneous group of membrane-enclosed nano-sized vesicles released by virtually all cells, of which their RNA cargo, especially non-coding RNAs (ncRNA), has been increasingly recognized as a promising diagnostic and therapeutic target. Recent evidence shows that ncRNAs, such as small ncRNAs, circular RNAs, and long ncRNAs, can be selectively sorted into EVs or other non-vesicular carriers and modulate various biological processes in recipient cells. In this review, we summarize recent advances in the literature regarding the origin, extr</pubmed_abstract><journal>Pharmaceutics</journal><pubmed_title>Extracellular Non-Coding RNAs in Cardiovascular Diseases.</pubmed_title><pmcid>PMC9865796</pmcid><funding_grant_id>81900287</funding_grant_id><funding_grant_id>219863</funding_grant_id><funding_grant_id>2019Q066</funding_grant_id><funding_grant_id>82205088</funding_grant_id><pubmed_authors>Yang X</pubmed_authors><pubmed_authors>Sun L</pubmed_authors><pubmed_authors>Li G</pubmed_authors><pubmed_authors>Li C</pubmed_authors><pubmed_authors>Lei J</pubmed_authors><pubmed_authors>Zhang L</pubmed_authors><pubmed_authors>Chatterjee E</pubmed_authors><pubmed_authors>Jiapaer Z</pubmed_authors></additional><is_claimable>false</is_claimable><name>Extracellular Non-Coding RNAs in Cardiovascular Diseases.</name><description>Cardiovascular diseases (CVDs) remain the world's leading cause of death despite the best available healthcare and therapy. Emerging as a key mediator of intercellular and inter-organ communication in CVD pathogenesis, extracellular vesicles (EVs) are a heterogeneous group of membrane-enclosed nano-sized vesicles released by virtually all cells, of which their RNA cargo, especially non-coding RNAs (ncRNA), has been increasingly recognized as a promising diagnostic and therapeutic target. Recent evidence shows that ncRNAs, such as small ncRNAs, circular RNAs, and long ncRNAs, can be selectively sorted into EVs or other non-vesicular carriers and modulate various biological processes in recipient cells. In this review, we summarize recent advances in the literature regarding the origin, extr</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Jan</publication><modification>2025-04-04T10:21:26.095Z</modification><creation>2025-02-19T00:12:52.752Z</creation></dates><accession>S-EPMC9865796</accession><cross_references><pubmed>36678784</pubmed><doi>10.3390/pharmaceutics15010155</doi></cross_references></HashMap>